Tizanidine

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 51655-603
  • Package NDC 51655-603-20
  • Package NDC 51655-603-26
  • Package NDC 51655-603-52
  • Package NDC 51655-603-54
  • Application number ANDA076286
  • SPL ID 4a65db4c-b8f9-9bba-e063-6394a90aa8bc
  • SPL set ID da31fbeb-3781-5e75-e053-2a95a90adb73
  • UNII B53E3NMY5C
  • RxCUI 313413

What the source publishes

Labeler
Northwind Health Company, LLC
Active ingredients
Tizanidine
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:51655-603_4a65db4c-b8f9-9bba-e063-6394a90aa8bc
{
  "name": "Tizanidine",
  "splId": "4a65db4c-b8f9-9bba-e063-6394a90aa8bc",
  "labels": [
    {
      "setId": "da31fbeb-3781-5e75-e053-2a95a90adb73",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=da31fbeb-3781-5e75-e053-2a95a90adb73",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=da31fbeb-3781-5e75-e053-2a95a90adb73"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Northwind Health Company, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "20 TABLET in 1 BOTTLE, PLASTIC (51655-603-20)",
      "package_ndc": "51655-603-20",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210219"
    },
    {
      "sample": false,
      "description": "90 TABLET in 1 BOTTLE, PLASTIC (51655-603-26)",
      "package_ndc": "51655-603-26",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210401"
    },
    {
      "sample": false,
      "description": "30 TABLET in 1 BOTTLE, PLASTIC (51655-603-52)",
      "package_ndc": "51655-603-52",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210407"
    },
    {
      "sample": false,
      "description": "15 TABLET in 1 BOTTLE, PLASTIC (51655-603-54)",
      "package_ndc": "51655-603-54",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20210719"
    }
  ],
  "productId": "51655-603_4a65db4c-b8f9-9bba-e063-6394a90aa8bc",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "51655-603",
  "deaSchedule": null,
  "genericName": "Tizanidine",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TIZANIDINE HYDROCHLORIDE",
      "strength": "4 mg/1"
    }
  ],
  "applicationNumber": "ANDA076286",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20210219",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "B53E3NMY5C"
    ],
    "rxcui": [
      "313413"
    ],
    "spl_set_id": [
      "da31fbeb-3781-5e75-e053-2a95a90adb73"
    ],
    "manufacturer_name": [
      "Northwind Health Company, LLC"
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:51655-603_4a65db4c-b8f9-9bba-e063-6394a90aa8bc"